SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization

Recruiting now · Not applicable

Conditions studied: Plantar Fascitis, Heel Pain, Musculoskeletal Diseases

In brief

This is a prospective, single center, double arm, randomized, unmasked, First in Human study that aims to evaluate the safety and effectiveness of SakuraBead™ resorbable embolization microspheres in adult patients suffering from pain secondary to plantar fasciitis.

Key facts

Study ID

NCT07241884

Run by

CrannMed

People needed

45

Starts

2025-10-20

Expected to finish

2027-03-01

Last updated by the study team

2025-11-21

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is able and willing to provide written informed consent, and
• Age 18 to 75 years (inclusive), and
• Clinical diagnosis of PF with proximal plantar fascia thickness greater than 4mm and areas of hypoechogenicity.

You may not qualify if…

• Acute internal derangement of the foot including acute meniscal, ligament or bone injury, or
• Sensory or motor neuropathy of the feet, or
• Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis, or
• Prior surgical repair or plantar fascia rupture in the involved foot, or
• Local infection in either foot, or
• Contraindication to MRI, or
• Active pregnancy as demonstrated by urine or serum β-hCG or lactating female
• Unable to provide informed consent or comply with the conditions of the study, or
• At the discretion of the Principal Investigator

Where it is running

• Nano Medical Clinic — Tashkent, Uzbekistan, Uzbekistan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.